Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients

Roche Diagnostics announced today that the US Food and Drug Administration (FDA) has cleared its cobas pro ® integrated solutions, a new generation of Serum Work Area (clinical chemistry and immunochemistry) laboratory solution, designed to optimize lab operations.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news